Indo-Bangla Pharmaceuticals Limited engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally. Its principal products include analgesics and antipyretics, anthelmintic, anti-asthmatic, gastroprokinetic and antiemetic, antiprotozoal, non-hormone sex stimulant, non-steroidal, anti-inflammatory, steroids, and vitamins and minerals, as well as respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal categories. The company markets its products in various forms, such as tablets, capsules, intravenous fluids, liquids, suppositories, and injectables. Indo-Bangla Pharmaceuticals Limited was founded in 1954 and is based in Dhaka, Bangladesh.
Metrics to compare | INDO | Peers Peers - average of corresponding metrics from companies closely matching INDO: CENTRALPHL, ORIONPHARM, BEACONPHAR, TECHNODRUG, SILCOPHL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINDOPeersSector |
---|---|---|---|---|
P/E Ratio | −33.6x | 10.6x | −0.5x | |
PEG Ratio | 0.34 | −0.28 | 0.00 | |
Price/Book | 1.0x | 1.3x | 2.6x | |
Price / LTM Sales | 17.0x | 2.1x | 3.3x | |
Upside (Analyst Target) | - | 44.2% | 38.7% | |
Fair Value Upside | Unlock | 1.9% | 5.0% | Unlock |